Business

Add as a preferred source on Google

Loblaw Reports 3.6% Sales Growth as Drug Retail Outpaces Food

Retail sales reached C$19.857 billion in the 16 weeks ended Oct. 10, while food same-store sales growth slowed to 0.6%.

Updated 2 min read
Customers enter a grocery store in Toronto, Canada, on an overcast autumn day. / EconoTimes.ai (mono)
Customers enter a grocery store in Toronto, Canada, on an overcast autumn day. / EconoTimes.ai (mono)

Loblaw Companies Limited reported 3.6% higher retail sales for the 16 weeks ended Oct. 10, as faster growth in its drug business contrasted with slower same-store sales at its Canadian food stores.

Sales totaled C$19.857 billion, up from the comparable 16-week period ended Oct. 4, 2025. Adjusted diluted net earnings per common share increased 8.8% to C$0.74, and adjusted net earnings rose 4.8% to C$857 million, the company said in its unaudited results.

Drug Retail sales rose 5.7% to C$5.809 billion, with same-store sales up 4.8%. Pharmacy and health care services same-store sales rose 7.6%, while front-store same-store sales rose 1.6%. Food Retail sales increased 2.8% to C$14.048 billion, but same-store sales growth slowed to 0.6% from 2.0% a year earlier.

Loblaw said its measure of food inflation was in line with Canada's 2.5% Consumer Price Index for Food Purchased From Stores. E-commerce sales increased 16.9% during the quarter.

Reported net earnings climbed 50.3% to C$1.193 billion, including a C$401 million gain, net of transaction costs, from the sale of PC Financial to EQB. The transaction closed July 1 for C$1.234 billion. Diluted net earnings per common share rose 56.1% to C$1.03.

Loblaw recorded C$9 million in adjusted income from equity-accounted investments, reflecting one month of its share of EQB Inc.'s earnings. The company said the sale's timing and EQB's July 31 quarter-end excluded two months from the quarter's contribution.

Retail operating income increased 9.7% to C$1.408 billion, and adjusted EBITDA rose 6.9% to C$2.250 billion. Gross profit percentage gained 20 basis points to 31.3%, with Loblaw citing strategic initiatives as the main contributor. Higher sales supported operating leverage, while new stores and an automated distribution facility added costs.

Loblaw opened 18 stores and closed one drug store. Gross capital investments totaled C$897 million, and the company repurchased and canceled 8.3 million common shares for C$524 million. President and CEO Per Bank said Loblaw was focused on delivering the value, quality, service and convenience customers expect across its retail network and digital platforms.

Related articles

View all